For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
Obamacare’s subsidy cliff: How many enrollees are actually affected?
Democrats in Congress have put Obamacare front and center in their opposition to the Republicans’ temporary budget. One provision of the American Rescue Plan…
National Review
RFK Jr.’s Cherry-Picked Science
One of Robert F. Kennedy Jr.’s promises as secretary of health and human services was to bring gold-standard science to our public…
Blog
The TrumpRx medicine will prove worse than the disease
On September 30, President Trump, standing alongside the CEO of Pfizer, announced a multifaceted deal wherein Pfizer would inoculate itself from new regulations and…
Search Posts
Blog
Obamacare’s subsidy cliff: How many enrollees are actually affected?
Democrats in Congress have put Obamacare front and center in their opposition to the Republicans’ temporary budget. One provision of the American Rescue Plan…
National Review
RFK Jr.’s Cherry-Picked Science
One of Robert F. Kennedy Jr.’s promises as secretary of health and human services was to bring gold-standard science to our public…
Blog
The TrumpRx medicine will prove worse than the disease
On September 30, President Trump, standing alongside the CEO of Pfizer, announced a multifaceted deal wherein Pfizer would inoculate itself from new regulations and…
Blog
Free the Economy podcast: Obamacare problems with Jeremy Nighohossian
In this week’s episode we talk about the unintended consequences of the Sarbanes-Oxley Act of 2002, decarbonization of economic growth, and resources…
Blog
The problem with Obamacare is Obamacare
This year, the COVID-induced expansion of the Affordable Care Act (ACA) will expire. Extending the expanded subsidies has become a point of contention between Republicans…
News Release
Report: Pharmaceutical tariffs will upend prices, supply
A new CEI report takes a close look at the complex, worldwide pharmaceutical supply chain to anticipate how forthcoming Trump tariffs might increase prices and…